1	CLEVELAND	cleveland	NNP	p2=NN	0	root	_
2	&	&	CC	_	1	cc	_
3	ATHENS	athens	NNP	_	1	conj	_
4	,	,	,	_	1	punct	_
5	Greece	greece	NNP	_	1	npadvmod	_
6	,	,	,	_	5	punct	_
7	May	may	NNP	_	5	conj	_
8	19	0	CD	_	7	num	_
9	,	,	,	_	7	punct	_
10	2014	0	CD	_	7	num	_
11	(	(	-LRB-	_	13	punct	_
12	BUSINESS	business	NNP	p2=NN	13	nn	_
13	WIRE	wire	NNP	_	5	appos	_
14	)	)	-RRB-	_	13	punct	_
15	--	--	:	_	1	punct	_
16	Juventas	juventas	NNP	_	17	nn	_
17	Therapeutics	therapeutics	NNP	p2=NNPS	1	appos	_
18	,	,	,	_	17	punct	_
19	Inc	inc	NNP	_	17	appos	_
20	.	.	.	_	1	punct	_

1	,	,	,	_	19	punct	_
2	a	a	DT	_	7	det	_
3	private	private	JJ	_	7	amod	_
4	clinical	clinical	JJ	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	stage	stage	NN	_	7	nn	_
7	company	company	NN	_	8	nsubj	_
8	developing	develop	VBG	pb=develop.01	19	advcl	19:AM-ADV
9	a	a	DT	_	13	det	_
10	drug	drug	NN	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	based	base	VBN	_	13	amod	_
13	approach	approach	NN	_	8	dobj	8:A1=LOC
14	to	to	IN	_	13	prep	_
15	regenerative	regenerative	JJ	p2=NN	16	amod	_
16	medicine	medicine	NN	_	14	pobj	_
17	,	,	,	_	19	punct	_
18	today	today	NN	_	19	npadvmod	19:AM-TMP
19	presented	present	VBD	p2=VBN|pb=present.01	0	root	_
20	top	top	JJ	_	22	hmod	_
21	-	-	HYPH	_	22	hyph	_
22	line	line	NN	_	24	nn	_
23	interim	interim	JJ	_	24	amod	_
24	data	datum	NNS	p2=NN	19	dobj	19:A1=PPT
25	from	from	IN	_	19	prep	19:A2=GOL
26	a	a	DT	p2=LS	31	det	_
27	Phase	phase	NNP	p2=NN	28	nn	_
28	II	ii	NNP	_	31	nn	_
29	study	study	NN	p2=VB	30	nn	_
30	evaluating	evaluate	VBG	_	31	nn	_
31	safety	safety	NN	_	25	pobj	_
32	and	and	CC	_	31	cc	_
33	efficacy	efficacy	NN	p2=NNS	31	conj	_
34	of	of	IN	_	31	prep	_
35	JVS	jvs	NNP	p2=NNS	37	hmod	_
36	-	-	HYPH	p2=SYM	37	hyph	_
37	100	0	CD	p2=NNP	34	pobj	_
38	in	in	IN	_	31	prep	_
39	patients	patient	NNS	_	38	pobj	_
40	with	with	IN	_	39	prep	_
41	symptomatic	symptomatic	JJ	_	43	amod	_
42	ischemic	ischemic	JJ	p2=NN	43	amod	_
43	cardiomyopathy	cardiomyopathy	NN	p2=NNS	40	pobj	_
44	at	at	IN	_	43	prep	_
45	the	the	DT	_	47	det	_
46	European	european	NNP	p2=JJ	47	nn	_
47	Society	society	NNP	_	44	pobj	_
48	of	of	IN	_	47	prep	_
49	Cardiology	cardiology	NN	p2=NNP	51	hmod	_
50	-	-	HYPH	_	51	hyph	_
51	Heart	heart	NN	p2=NNP	52	nn	_
52	Failure	failure	NN	p2=NNP	48	pobj	_
53	Congress	congress	NNP	_	48	pobj	_
54	in	in	IN	_	52	prep	_
55	Athens	athens	NNP	_	54	pobj	_
56	,	,	,	_	55	punct	_
57	Greece	greece	NNP	_	55	appos	_
58	.	.	.	_	19	punct	_

1	In	in	IN	_	75	prep	75:AM-LOC
2	an	an	DT	_	4	det	_
3	oral	oral	JJ	_	4	amod	_
4	presentation	presentation	NN	_	1	pobj	5:A1=PPT
5	accepted	accept	VBN	pb=accept.01	4	partmod	_
6	as	as	IN	_	42	mark	_
7	a	a	DT	_	12	det	_
8	late	late	RB	_	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	breaking	break	VBG	_	12	amod	_
11	clinical	clinical	JJ	_	12	amod	_
12	trial	trial	NN	_	42	nsubj	42:A0=PAG
13	,	,	,	_	12	punct	_
14	Marc	marc	NNP	_	15	nn	_
15	Penn	penn	NNP	_	12	appos	_
16	,	,	,	_	15	punct	_
17	M.D.	m.d.	NNP	_	15	conj	_
18	,	,	,	_	17	punct	_
19	Ph.D.	ph.d.	NNP	p2=NN	17	conj	_
20	,	,	,	_	19	punct	_
21	Founder	founder	NNP	_	19	conj	_
22	and	and	CC	_	21	cc	_
23	Chief	chief	NNP	_	25	nn	_
24	Medical	medical	NNP	_	25	nn	_
25	Officer	officer	NNP	_	21	conj	_
26	for	for	IN	_	21	prep	_
27	Juventas	juventas	NNP	_	26	pobj	_
28	and	and	CC	_	27	cc	_
29	Director	director	NNP	_	27	conj	_
30	of	of	IN	_	27	prep	_
31	Cardiovascular	cardiovascular	NNP	_	32	nn	_
32	Research	research	NNP	_	30	pobj	_
33	at	at	IN	_	21	prep	_
34	Summa	summa	NNP	_	38	nn	_
35	Health	health	NNP	_	36	nn	_
36	System	system	NNP	_	33	pobj	_
37	,	,	,	_	21	punct	_
38	Akron	akron	NNP	_	21	conj	_
39	,	,	,	_	38	punct	_
40	Ohio	ohio	NNP	_	38	appos	_
41	,	,	,	_	38	punct	_
42	presented	present	VBD	pb=present.01	5	advcl	_
43	the	the	DT	_	45	det	_
44	interim	interim	JJ	_	45	amod	_
45	data	datum	NNS	p2=NN	42	dobj	42:A1=PPT
46	from	from	IN	_	45	prep	_
47	the	the	DT	_	51	det	_
48	STOP	stop	NNP	_	50	hmod	_
49	-	-	HYPH	_	50	hyph	_
50	HF	hf	NNP	_	51	nn	_
51	trial	trial	NN	_	46	pobj	53:A0=CAU
52	that	that	WDT	p2=DT	53	nsubj	53:R-A0
53	shows	show	VBZ	pb=show.01	51	rcmod	_
54	JVS	jvs	NNP	p2=NNS	56	hmod	_
55	-	-	HYPH	_	56	hyph	_
56	100	0	CD	p2=NNP	53	dobj	_
57	,	,	,	_	51	punct	_
58	a	a	DT	_	61	det	_
59	non-viral	non-viral	JJ	_	61	amod	_
60	gene	gene	NN	_	61	nn	_
61	therapy	therapy	NN	_	51	appos	62:A0=PAG
62	expressing	express	VBG	pb=express.01	61	partmod	_
63	stromal	stromal	JJ	_	67	amod	_
64	cell	cell	NN	_	66	hmod	_
65	-	-	HYPH	_	66	hyph	_
66	derived	derive	VBN	_	67	amod	_
67	factor	factor	NN	_	62	dobj	62:A1=PPT
68	1	0	CD	_	67	num	_
69	(	(	-LRB-	_	67	punct	_
70	SDF	sdf	NNP	_	72	hmod	_
71	-	-	HYPH	p2=:	72	hyph	_
72	1	1	NNP	p2=CD	67	appos	_
73	)	)	-RRB-	_	67	punct	_
74	,	,	,	_	12	punct	_
75	improves	improve	VBZ	pb=improve.01	0	root	_
76	cardiac	cardiac	JJ	_	77	amod	_
77	function	function	NN	_	75	dobj	75:A1=PPT
78	in	in	IN	_	75	prep	_
79	patients	patient	NNS	_	78	pobj	_
80	with	with	IN	_	79	prep	_
81	advanced	advanced	JJ	_	83	amod	_
82	heart	heart	NN	_	83	nn	_
83	failure	failure	NN	p2=VBP	80	pobj	_
84	more	more	JJR	p2=RBR	88	advmod	_
85	than	than	IN	_	84	prep	_
86	a	a	DT	_	87	det	_
87	decade	decade	NN	_	85	pobj	_
88	after	after	IN	_	75	prep	_
89	having	have	VBG	pb=have.03	88	pcomp	_
90	a	a	DT	_	92	det	_
91	heart	heart	NN	_	92	nn	_
92	attack	attack	NN	_	89	dobj	89:A1=PPT
93	.	.	.	_	75	punct	_

1	SDF	sdf	NNP	p2=IN	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	1	1	NNP	p2=CD	6	nsubjpass	6:A1=PPT
4	has	have	VBZ	_	6	aux	_
5	been	be	VBN	_	6	auxpass	_
6	shown	show	VBN	pb=show.01	0	root	_
7	in	in	IN	_	6	prep	6:AM-LOC
8	previous	previous	JJ	_	9	amod	_
9	studies	study	NNS	_	7	pobj	_
10	to	to	TO	_	11	aux	_
11	promote	promote	VB	pb=promote.02	9	infmod	_
12	tissue	tissue	NN	p2=VB	13	nn	_
13	repair	repair	NN	p2=VB	11	dobj	11:A1=PPT
14	through	through	IN	_	11	prep	11:AM-MNR
15	activating	activate	VBG	pb=activate.01	14	pcomp	_
16	an	an	DT	_	21	det	_
17	endogenous	endogenous	JJ	_	21	amod	_
18	stem	stem	NN	p2=JJ	19	nn	_
19	cell	cell	NN	_	20	nn	_
20	repair	repair	NN	p2=VB	21	nn	_
21	pathway	pathway	NN	p2=RB	15	dobj	15:A1=PPT
22	.	.	.	_	6	punct	_

1	At	at	IN	_	22	prep	22:AM-TMP
2	the	the	DT	_	3	det	_
3	time	time	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	7	det	_
6	interim	interim	JJ	_	7	amod	_
7	analysis	analysis	NN	_	4	pobj	_
8	,	,	,	_	22	punct	_
9	93	0	CD	_	13	num	_
10	ischemic	ischemic	JJ	p2=NN	13	amod	_
11	symptomatic	symptomatic	JJ	_	13	amod	_
12	cardiomyopathy	cardiomyopathy	NN	p2=JJ	13	nn	_
13	patients	patient	NNS	_	22	nsubjpass	22:A1=PPT
14	with	with	IN	_	13	prep	_
15	prior	prior	JJ	_	16	amod	_
16	history	history	NN	_	14	pobj	_
17	of	of	IN	_	16	prep	_
18	a	a	DT	_	20	det	_
19	heart	heart	NN	_	20	nn	_
20	attack	attack	NN	_	17	pobj	_
21	were	be	VBD	_	22	auxpass	_
22	randomized	randomize	VBN	pb=randomize.01	0	root	_
23	on	on	IN	_	22	prep	22:A2=GOL
24	a	a	DT	_	28	det	_
25	1:1	0	CD	p2=NN	28	nn	_
26	:	:	SYM	p2=:	27	punct	_
27	1	0	CD	_	25	prep	_
28	ratio	ratio	NN	_	23	pobj	_
29	to	to	TO	_	30	aux	_
30	receive	receive	VB	pb=receive.01	22	advcl	22:AM-PRP
31	a	a	DT	_	33	det	_
32	single	single	JJ	_	33	amod	_
33	treatment	treatment	NN	_	30	dobj	30:A1=PPT
34	of	of	IN	_	33	prep	_
35	either	either	CC	p2=DT	37	preconj	_
36	15	0	CD	_	37	num	_
37	mg	mg	NNS	p2=NN	34	pobj	_
38	or	or	CC	_	37	cc	_
39	30	0	CD	_	40	num	_
40	mg	mg	NNS	p2=NN	37	conj	_
41	of	of	IN	_	40	prep	_
42	JVS	jvs	NNP	p2=NNPS	44	hmod	_
43	-	-	HYPH	_	44	hyph	_
44	100	0	CD	_	41	pobj	_
45	or	or	CC	_	44	cc	_
46	matching	match	VBG	p2=JJ|pb=match.01	44	conj	_
47	placebo	placebo	NN	_	46	dobj	46:A1=PPT
48	.	.	.	_	22	punct	_

1	Objective	objective	JJ	_	4	amod	_
2	and	and	CC	_	1	cc	_
3	subjective	subjective	JJ	_	1	conj	_
4	measures	measure	NNS	_	10	nsubjpass	10:A1=PPT
5	of	of	IN	_	4	prep	_
6	clinical	clinical	JJ	_	7	amod	_
7	status	status	NN	_	5	pobj	_
8	are	be	VBP	_	10	aux	_
9	being	be	VBG	_	10	auxpass	_
10	assessed	assess	VBN	pb=assess.01	0	root	_
11	in	in	IN	_	10	prep	10:AM-LOC
12	all	all	DT	_	13	det	_
13	patients	patient	NNS	_	11	pobj	_
14	at	at	IN	_	10	prep	10:AM-TMP
15	120	0	CD	_	16	num	_
16	days	day	NNS	_	14	pobj	_
17	(	(	-LRB-	_	10	punct	_
18	4	0	CD	_	19	num	_
19	months	month	NNS	_	10	npadvmod	10:A2=PRD
20	)	)	-RRB-	_	10	punct	_
21	,	,	,	_	10	punct	_
22	and	and	CC	_	10	cc	_
23	360	0	CD	_	24	num	_
24	days	day	NNS	_	29	nn	_
25	(	(	-LRB-	_	24	punct	_
26	12	0	CD	_	27	num	_
27	months	month	NNS	_	24	appos	_
28	)	)	-RRB-	_	24	punct	_
29	post-injection	post-injection	NN	p2=JJ	10	conj	_
30	.	.	.	_	10	punct	_

1	The	the	DT	_	2	det	_
2	study	study	NN	_	3	nsubj	3:A0
3	demonstrated	demonstrate	VBD	pb=demonstrate.01	0	root	_
4	that	that	IN	p2=DT	10	complm	_
5	JVS	jvs	NNP	p2=NNS	7	hmod	_
6	-	-	HYPH	p2=SYM	7	hyph	_
7	100	100	NNP	p2=CD	10	nsubjpass	10:A1
8	was	be	VBD	_	10	auxpass	_
9	well	well	RB	p2=UH	10	advmod	10:AM-MNR
10	tolerated	tolerate	VBN	pb=tolerate.01	3	ccomp	3:A1=PPT
11	in	in	IN	p2=RP	10	prep	10:AM-LOC
12	all	all	DT	_	13	det	_
13	patients	patient	NNS	_	11	pobj	_
14	with	with	IN	_	13	prep	_
15	no	no	DT	_	18	det	_
16	serious	serious	JJ	_	18	amod	_
17	side	side	NN	_	18	nn	_
18	effects	effect	NNS	_	14	pobj	_
19	.	.	.	_	3	punct	_

1	To	to	IN	_	10	prep	10:AM-TMP
2	date	date	NN	_	1	pobj	_
3	,	,	,	_	10	punct	_
4	JVS	jvs	NNP	p2=NNPS	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	100	100	NNP	p2=CD	10	nsubjpass	10:A1=PPT
7	has	have	VBZ	_	10	aux	_
8	been	be	VBN	_	10	auxpass	_
9	safely	safely	RB	_	10	advmod	10:AM-MNR
10	delivered	deliver	VBN	pb=deliver.01	0	root	_
11	to	to	IN	_	10	prep	10:A2=GOL
12	more	more	JJR	_	14	amod	_
13	than	than	IN	_	14	quantmod	_
14	150	0	CD	_	15	num	_
15	patients	patient	NNS	_	11	pobj	_
16	across	across	IN	_	15	prep	_
17	multiple	multiple	JJ	_	19	amod	_
18	clinical	clinical	JJ	_	19	amod	_
19	trials	trial	NNS	_	16	pobj	_
20	.	.	.	_	10	punct	_

1	Interim	interim	JJ	p2=IN	9	amod	_
2	top	top	JJ	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	line	line	NN	_	9	nn	_
5	four	#crd#	CD	_	7	hmod	_
6	-	-	HYPH	_	7	hyph	_
7	month	month	NN	_	9	nn	_
8	efficacy	efficacy	NN	p2=JJ	9	nn	_
9	data	datum	NNS	p2=NN	10	nsubj	10:A0
10	demonstrated	demonstrate	VBD	pb=demonstrate.01	0	root	_
11	dose	dose	NN	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	dependent	dependent	JJ	_	14	amod	_
14	improvements	improvement	NNS	_	10	dobj	10:A1=PPT
15	in	in	IN	_	14	prep	_
16	echocardiographic	echocardiographic	JJ	_	17	amod	_
17	parameters	parameter	NNS	_	15	pobj	_
18	and	and	CC	_	17	cc	_
19	biomarkers	biomarker	NNS	_	17	conj	_
20	for	for	IN	_	17	prep	_
21	patients	patient	NNS	_	20	pobj	23:A0=PAG
22	having	have	VBG	_	23	aux	_
23	received	receive	VBN	pb=receive.01	21	partmod	_
24	JVS	jvs	NNP	p2=NNS	26	hmod	_
25	-	-	HYPH	_	26	hyph	_
26	100	0	CD	p2=NNP	23	dobj	23:A1=PPT
27	.	.	.	_	10	punct	_

1	Specifically	specifically	RB	_	22	advmod	_
2	,	,	,	_	22	punct	_
3	a	a	DT	_	4	det	_
4	subpopulation	subpopulation	NN	_	22	nsubj	22:A0;40:A0=PAG;50:A0
5	of	of	IN	_	4	prep	_
6	high	high	JJ	_	7	amod	_
7	risk	risk	NN	_	8	nn	_
8	patients	patient	NNS	_	5	pobj	10:A0=PAG
9	who	who	WP	_	10	nsubj	10:R-A0
10	received	receive	VBD	pb=receive.01	8	rcmod	_
11	the	the	DT	_	13	det	_
12	high	high	JJ	_	13	amod	_
13	dose	dose	NN	_	10	dobj	10:A1=PPT
14	of	of	IN	_	13	prep	_
15	JVS	jvs	NNP	p2=NNS	17	hmod	_
16	-	-	HYPH	_	17	hyph	_
17	100	0	CD	_	14	pobj	_
18	(	(	-LRB-	_	20	punct	_
19	30	0	CD	_	20	num	_
20	mg	mg	NN	p2=NNS	17	appos	_
21	)	)	-RRB-	_	20	punct	_
22	demonstrated	demonstrate	VBD	p2=VBN|pb=demonstrate.01	0	root	_
23	improvements	improvement	NNS	_	22	dobj	_
24	relative	relative	JJ	_	23	amod	_
25	to	to	IN	_	24	prep	_
26	placebo	placebo	NN	_	25	pobj	_
27	in	in	IN	_	26	prep	_
28	left	leave	VBN	p2=JJ|pb=leave.06	32	amod	_
29	ventricular	ventricular	JJ	p2=NN	30	amod	_
30	end	end	NN	_	31	nn	_
31	systolic	systolic	NN	p2=JJ	32	nn	_
32	volume	volume	NN	_	27	pobj	28:A1=PPT
33	(	(	-LRB-	_	32	punct	_
34	LVESV	lvesv	NNP	p2=NN	32	appos	_
35	)	)	-RRB-	_	32	punct	_
36	p	p	VBZ	p2=IN|pb=p.01	22	ccomp	22:A1=PPT
37	<	<	XX	p2=$	38	nmod	_
38	0.05	0	CD	_	36	dobj	36:A1
39	,	,	,	_	22	punct	_
40	left	leave	VBD	p2=VBN|pb=leave.02	22	conj	_
41	ventricular	ventricular	JJ	_	42	amod	_
42	end	end	NN	_	40	dobj	40:A1=PPT
43	diastolic	diastolic	JJ	p2=NN	44	amod	_
44	volume	volume	NN	_	40	npadvmod	40:A2=GOL
45	(	(	-LRB-	_	44	punct	_
46	LVEDV	lvedv	NNP	p2=NN	44	appos	_
47	)	)	-RRB-	_	44	punct	_
48	p=0.11	p=0	NN	p2=NNP	40	npadvmod	40:AM-TMP
49	,	,	,	_	40	punct	_
50	left	leave	VBD	p2=VBN|pb=leave.01	40	conj	_
51	ventricular	ventricular	JJ	p2=RB	53	amod	_
52	ejection	ejection	NN	_	53	nn	_
53	fraction	fraction	NN	_	50	dobj	50:A1=DIR
54	(	(	-LRB-	_	53	punct	_
55	LVEF	lvef	NNP	p2=NN	53	appos	_
56	)	)	-RRB-	_	53	punct	_
57	p=0.23	p=0	NN	p2=NNP	50	oprd	50:A2=PRD
58	and	and	CC	_	57	cc	_
59	NTproBNP	ntprobnp	NNP	_	60	nn	_
60	levels	level	NNS	_	57	conj	_
61	(	(	-LRB-	_	65	punct	_
62	a	a	DT	_	65	det	_
63	simple	simple	JJ	_	65	amod	_
64	blood	blood	NN	_	65	nn	_
65	test	test	NN	_	60	appos	67:A0
66	that	that	WDT	_	67	nsubj	67:R-A0
67	predicts	predict	VBZ	pb=predict.01	65	rcmod	_
68	the	the	DT	_	69	det	_
69	risk	risk	NN	_	81	nn	_
70	of	of	IN	_	69	prep	_
71	worsening	worsen	VBG	pb=worsen.01	70	pcomp	_
72	heart	heart	NN	p2=JJ	73	nn	_
73	failure	failure	NN	_	71	dobj	71:A1=PPT
74	in	in	IN	_	71	prep	_
75	patients	patient	NNS	_	74	pobj	_
76	with	with	IN	_	75	prep	_
77	known	know	VBN	p2=JJ|pb=know.01	79	amod	_
78	cardiovascular	cardiovascular	JJ	_	79	amod	_
79	disease	disease	NN	_	76	pobj	77:A1=PPT
80	)	)	-RRB-	_	81	punct	_
81	p=0.12	p=0	NN	p2=''	67	ccomp	67:A1=PPT
82	.	.	.	_	22	punct	_

1	Study	study	NN	p2=JJ	2	nn	_
2	drug	drug	NN	_	4	nsubjpass	4:A1=PPT
3	was	be	VBD	_	4	auxpass	_
4	administered	administer	VBN	pb=administer.01	0	root	_
5	directly	directly	RB	_	4	advmod	4:AM-MNR
6	to	to	IN	_	4	prep	4:A2=GOL
7	the	the	DT	_	8	det	_
8	heart	heart	NN	_	6	pobj	_
9	via	via	IN	_	4	prep	4:AM-MNR
10	the	the	DT	_	14	det	_
11	BioCardia	biocardia	NNP	p2=NN	12	nn	_
12	Helical	helical	NNP	_	14	nn	_
13	Infusion	infusion	NNP	_	14	nn	_
14	Catheter	catheter	NNP	_	9	pobj	22:A1=PRD
15	(	(	-LRB-	_	14	punct	_
16	HIC	hic	NNP	_	14	appos	_
17	)	)	-RRB-	_	14	punct	_
18	,	,	,	_	14	punct	_
19	which	which	WDT	_	22	nsubjpass	22:R-A1
20	is	be	VBZ	_	22	aux	_
21	being	be	VBG	_	22	auxpass	_
22	developed	develop	VBN	pb=develop.02	14	rcmod	_
23	by	by	IN	_	22	agent	22:A0=PAG
24	BioCardia	biocardia	NNP	_	23	pobj	_
25	,	,	,	_	24	punct	_
26	Inc	inc	NNP	_	24	appos	_
27	.	.	.	_	4	punct	_

1	,	,	,	_	6	punct	_
2	of	of	IN	_	0	root	_
3	San	san	NNP	_	4	nn	_
4	Carlos	carlos	NNP	_	2	pobj	_
5	,	,	,	_	4	punct	_
6	Calif	calif	NNP	_	4	appos	_
7	.	.	.	_	6	punct	_

1	The	the	DT	_	2	det	_
2	HIC	hic	NNP	p2=NN	3	nsubj	3:A0=PAG;14:A0=PAG
3	allows	allow	VBZ	pb=allow.01	0	root	_
4	for	for	IN	_	3	prep	3:A1=PPT
5	percutaneous	percutaneous	JJ	_	6	amod	_
6	delivery	delivery	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	biologics	biologics	NNS	p2=NN	7	pobj	_
9	to	to	TO	_	10	aux	_
10	treat	treat	VB	pb=treat.03	8	infmod	_
11	cardiovascular	cardiovascular	JJ	_	12	amod	_
12	disease	disease	NN	_	10	dobj	10:A2=PPT
13	and	and	CC	_	3	cc	_
14	provides	provide	VBZ	pb=provide.01	3	conj	_
15	a	a	DT	_	18	det	_
16	new	new	JJ	_	18	amod	_
17	therapeutic	therapeutic	JJ	_	18	amod	_
18	option	option	NN	_	14	dobj	14:A1=PPT
19	for	for	IN	_	18	prep	_
20	patients	patient	NNS	_	19	pobj	_
21	with	with	IN	_	20	prep	_
22	heart	heart	NN	_	23	nn	_
23	failure	failure	NN	_	21	pobj	_
24	and	and	CC	_	23	cc	_
25	chronic	chronic	JJ	_	26	amod	_
26	myocardial	myocardial	JJ	p2=NN	27	amod	_
27	ischemia	ischemia	NN	_	23	conj	_
28	.	.	.	_	3	punct	_

1	JVS	jv	NNS	p2=NNP	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	100	0	CD	_	0	root	5:A1=PPT
4	,	,	,	_	5	punct	_
5	is	be	VBZ	pb=be.01	0	root	_
6	a	a	DT	_	8	det	_
7	non-viral	non-viral	JJ	_	8	amod	_
8	plasmid	plasmid	NN	_	5	nsubj	10:A0=PAG;5:A2=PRD
9	that	that	WDT	p2=IN	10	nsubj	10:R-A0
10	encodes	encode	VBZ	p2=RB|pb=encode.01	8	rcmod	_
11	for	for	IN	_	10	prep	10:AM-TMP
12	stromal	stromal	JJ	p2=NN	18	amod	_
13	cell	cell	NN	_	15	hmod	_
14	-	-	HYPH	p2=,	15	hyph	_
15	derived	derive	VBN	_	16	amod	_
16	factor	factor	NN	_	18	hmod	_
17	-	-	HYPH	p2=,	18	hyph	_
18	1	0	CD	_	11	pobj	_
19	(	(	-LRB-	_	22	punct	_
20	SDF	sdf	NNP	p2=CD	22	hmod	_
21	-	-	HYPH	p2=:	22	hyph	_
22	1	1	NNP	p2=CD	10	dobj	_
23	)	)	-RRB-	_	22	punct	_
24	.	.	.	_	5	punct	_

1	SDF	sdf	NNP	p2=IN	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	1	1	NNP	p2=CD	4	nsubj	4:A0=PAG
4	promotes	promote	VBZ	pb=promote.02	0	root	_
5	cardiac	cardiac	JJ	p2=NN	6	amod	_
6	function	function	NN	_	4	dobj	4:A1=PPT
7	and	and	CC	_	6	cc	_
8	tissue	tissue	NN	p2=VB	9	nn	_
9	repair	repair	NN	p2=VBP	6	conj	_
10	following	follow	VBG	_	4	prep	4:AM-TMP
11	a	a	DT	_	13	det	_
12	heart	heart	NN	_	13	nn	_
13	attack	attack	NN	_	10	pobj	_
14	through	through	IN	_	13	prep	_
15	activation	activation	NN	_	14	pobj	_
16	of	of	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	body	body	NN	_	27	poss	_
19	's	's	POS	_	18	possessive	_
20	natural	natural	JJ	_	21	amod	_
21	stem	stem	NN	_	23	hmod	_
22	-	-	HYPH	_	23	hyph	_
23	cell	cell	NN	_	27	nn	_
24	based	base	VBN	pb=base.02	27	amod	_
25	regenerative	regenerative	JJ	p2=NN	27	amod	_
26	repair	repair	NN	_	27	nn	_
27	processes	process	NNS	_	16	pobj	24:A1=PPT
28	.	.	.	_	4	punct	_

1	JVS	jv	NNS	p2=NNP	3	hmod	_
2	-	-	HYPH	p2=SYM	3	hyph	_
3	100	0	CD	p2=NN	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	the	the	DT	_	6	det	_
6	subject	subject	NN	_	4	attr	4:A2=PRD
7	of	of	IN	_	6	prep	_
8	active	active	JJ	_	10	amod	_
9	clinical	clinical	JJ	_	10	amod	_
10	programs	program	NNS	_	7	pobj	_
11	in	in	IN	_	10	prep	_
12	heart	heart	NN	_	13	nn	_
13	failure	failure	NN	_	11	pobj	_
14	(	(	-LRB-	_	13	punct	_
15	HF	hf	NNP	p2=NN	13	appos	_
16	)	)	-RRB-	_	13	punct	_
17	and	and	CC	_	6	cc	_
18	critical	critical	JJ	_	20	amod	_
19	limb	limb	NN	_	20	nn	_
20	ischemia	ischemia	NN	p2=NNS	6	conj	_
21	(	(	-LRB-	_	20	punct	_
22	CLI	cli	NNP	_	20	appos	_
23	)	)	-RRB-	_	20	punct	_
24	.	.	.	_	4	punct	_

1	JVS	jv	NNS	p2=NNP	3	hmod	_
2	-	-	HYPH	p2=SYM	3	hyph	_
3	100	0	CD	p2=NN	31	num	_
4	is	be	VBZ	_	16	auxpass	_
5	the	the	DT	_	6	det	_
6	focus	focus	NN	_	16	nsubj	14:A1=PPT;16:A1=PPT
7	of	of	IN	_	6	prep	_
8	an	an	DT	_	13	det	_
9	on	on	RB	p2=IN	11	hmod	_
10	-	-	HYPH	_	11	hyph	_
11	going	go	VBG	p2=JJ	13	amod	_
12	Phase	phase	NNP	p2=NN	13	nn	_
13	II	ii	NNP	_	7	pobj	_
14	blinded	blind	VBN	p2=VBN|pb=blind.01	6	partmod	_
15	,	,	,	_	16	punct	_
16	randomized	randomize	VBD	p2=JJ|pb=randomize.01	0	root	_
17	,	,	,	_	16	punct	_
18	placebo	placebo	NN	_	20	hmod	_
19	-	-	HYPH	_	20	hyph	_
20	controlled	control	VBN	_	21	amod	_
21	trial	trial	NN	_	16	dobj	_
22	,	,	,	_	21	punct	_
23	RETRO	retro	NNP	_	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	HF	hf	NNP	_	21	appos	30:A0
26	,	,	,	_	25	punct	_
27	which	which	WDT	_	30	nsubj	30:R-A0
28	is	be	VBZ	_	30	aux	_
29	currently	currently	RB	_	30	advmod	30:AM-TMP
30	enrolling	enrol	VBG	pb=enroll.01	25	rcmod	_
31	patients	patient	NNS	_	30	dobj	30:A1
32	similar	similar	JJ	_	30	advmod	30:A2
33	to	to	IN	_	32	prep	_
34	those	those	DT	_	33	pobj	35:A1
35	enrolled	enrol	VBN	pb=enroll.01	34	partmod	_
36	in	in	IN	_	35	prep	35:AM-LOC
37	STOP	stop	NNP	p2=NN	39	hmod	_
38	-	-	HYPH	p2=,	39	hyph	_
39	HF	hf	NNP	_	36	pobj	_
40	with	with	IN	_	35	prep	35:A2
41	delivery	delivery	NN	_	40	pobj	_
42	via	via	IN	_	41	prep	_
43	coronary	coronary	JJ	_	45	amod	_
44	sinus	sinus	JJ	p2=NN	45	amod	_
45	infusion	infusion	NN	_	42	pobj	_
46	.	.	.	_	14	punct	_

1	STOP	stop	NNP	p2=NN	3	hmod	_
2	-	-	HYPH	p2=:	3	hyph	_
3	HF	hf	NNP	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	62	ccomp	_
5	an	an	DT	_	9	det	_
6	exploratory	exploratory	JJ	_	9	amod	_
7	Phase	phase	NNP	p2=NN	8	nn	_
8	II	ii	NNP	_	9	nn	_
9	study	study	NN	_	4	attr	4:A2=PRD
10	of	of	IN	_	9	prep	_
11	93	0	CD	p2=NN	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	patients	patient	NNS	_	10	pobj	_
14	in	in	IN	_	9	prep	_
15	a	a	DT	_	25	det	_
16	double	double	JJ	_	18	hmod	_
17	-	-	HYPH	_	18	hyph	_
18	blind	blind	JJ	_	25	amod	_
19	,	,	,	_	25	punct	_
20	randomized	randomized	JJ	p2=VBD	25	amod	_
21	,	,	,	_	25	punct	_
22	placebo	placebo	NN	_	24	hmod	_
23	-	-	HYPH	_	24	hyph	_
24	controlled	control	VBN	_	25	amod	_
25	trial	trial	NN	_	14	pobj	27:A1=PPT
26	being	be	VBG	p2=NN	27	auxpass	_
27	conducted	conduct	VBN	pb=conduct.01	25	partmod	_
28	at	at	IN	_	27	prep	27:AM-LOC
29	15	0	CD	_	30	num	_
30	centers	center	NNS	_	28	pobj	_
31	in	in	IN	_	30	prep	_
32	the	the	DT	_	34	det	_
33	United	united	NNP	_	34	nn	_
34	States	states	NNP	p2=NNPS	31	pobj	_
35	to	to	TO	_	36	aux	_
36	evaluate	evaluate	VB	pb=evaluate.01	27	advcl	27:AM-PRP
37	safety	safety	NN	_	36	dobj	36:A1=PPT
38	and	and	CC	_	37	cc	_
39	efficacy	efficacy	NN	p2=NNS	37	conj	_
40	of	of	IN	_	37	prep	_
41	a	a	DT	_	43	det	_
42	single	single	JJ	_	43	amod	_
43	treatment	treatment	NN	_	40	pobj	_
44	of	of	IN	_	43	prep	_
45	JVS	jvs	NNP	p2=NN	47	hmod	_
46	-	-	HYPH	_	47	hyph	_
47	100	0	CD	p2=NNP	44	pobj	_
48	,	,	,	_	62	punct	_
49	a	a	DT	_	55	det	_
50	plasmid	plasmid	NN	p2=JJ	55	nn	_
51	stromal	stromal	JJ	p2=NN	52	amod	_
52	cell	cell	NN	_	54	hmod	_
53	-	-	HYPH	_	54	hyph	_
54	derived	derive	VBN	_	55	amod	_
55	factor	factor	NN	_	62	nsubj	62:A0=PAG
56	1	0	CD	_	55	num	_
57	(	(	-LRB-	_	60	punct	_
58	SDF	sdf	NNP	_	60	hmod	_
59	-	-	HYPH	p2=:	60	hyph	_
60	1	1	NNP	p2=CD	55	appos	_
61	)	)	-RRB-	_	60	punct	_
62	delivered	deliver	VBD	p2=VBN|pb=deliver.01	0	root	_
63	via	via	IN	_	62	prep	62:AM-MNR
64	injection	injection	NN	_	63	pobj	_
65	to	to	IN	_	62	prep	62:A2=GOL
66	the	the	DT	_	67	det	_
67	endocardium	endocardium	NN	_	65	pobj	_
68	and	and	CC	_	67	cc	_
69	myocardium	myocardium	NN	_	67	conj	_
70	of	of	IN	_	67	prep	_
71	patients	patient	NNS	_	70	pobj	_
72	with	with	IN	_	71	prep	_
73	ischemic	ischemic	JJ	_	75	amod	_
74	heart	heart	NN	_	75	nn	_
75	failure	failure	NN	_	72	pobj	_
76	.	.	.	_	62	punct	_

1	Patients	patient	NNS	_	2	nsubj	2:A1
2	enrolled	enrol	VBD	p2=VBN|pb=enroll.01	7	ccomp	_
3	in	in	IN	p2=RP	2	prep	2:AM-LOC
4	STOP	stop	NNP	p2=NN	6	hmod	_
5	-	-	HYPH	p2=,	6	hyph	_
6	HF	hf	NNP	_	3	pobj	_
7	have	have	VBP	p2=VB|pb=have.03	0	root	_
8	a	a	DT	_	10	det	_
9	prior	prior	JJ	_	10	amod	_
10	history	history	NN	_	7	dobj	7:A1=PPT
11	of	of	IN	_	10	prep	_
12	a	a	DT	_	14	det	_
13	heart	heart	NN	_	14	nn	_
14	attack	attack	NN	_	11	pobj	_
15	and	and	CC	_	7	cc	_
16	years	year	NNS	_	18	nsubj	18:AM-TMP
17	later	later	RB	_	18	advmod	18:AM-TMP
18	developed	develop	VBD	p2=VBN|pb=develop.01	7	conj	_
19	symptomatic	symptomatic	JJ	_	21	amod	_
20	heart	heart	NN	_	21	nn	_
21	failure	failure	NN	_	18	dobj	18:A1=LOC
22	as	as	IN	_	23	mark	_
23	defined	define	VBN	pb=define.01	18	advcl	18:AM-ADV
24	by	by	IN	_	23	agent	23:R-A0=PAG
25	an	an	DT	_	27	det	_
26	ejection	ejection	NN	_	27	nn	_
27	fraction	fraction	NN	_	24	pobj	_
28	(	(	-LRB-	_	30	punct	_
29	a	a	DT	_	30	det	_
30	measurement	measurement	NN	_	27	appos	_
31	of	of	IN	_	30	prep	_
32	how	how	WRB	_	33	advmod	_
33	well	well	RB	_	37	advmod	37:R-AM-MNR
34	your	your	PRP$	_	35	poss	_
35	heart	heart	NN	_	37	nsubj	37:A1=GOL
36	is	be	VBZ	_	37	aux	_
37	pumping	pump	VBG	p2=NN|pb=pump.01	31	pcomp	_
38	)	)	-RRB-	_	37	punct	_
39	less	less	JJR	p2=CC	42	advmod	_
40	than	than	IN	_	39	prep	_
41	or	or	CC	_	39	cc	_
42	equal	equal	JJ	p2=RB	10	amod	_
43	to	to	IN	_	42	prep	_
44	40	0	CD	_	45	num	_
45	percent	percent	NN	_	43	pobj	_
46	and	and	CC	_	45	cc	_
47	poor	poor	JJ	_	48	amod	_
48	quality	quality	NN	_	45	conj	_
49	of	of	IN	_	48	prep	_
50	life	life	NN	_	53	nn	_
51	and	and	CC	_	50	cc	_
52	exercise	exercise	NN	p2=VB	50	conj	_
53	tolerance	tolerance	NN	_	49	pobj	_
54	as	as	IN	_	55	mark	_
55	measured	measure	VBN	pb=measure.01	53	advcl	_
56	by	by	IN	_	55	agent	_
57	the	the	DT	_	59	det	_
58	Minnesota	minnesota	NNP	_	59	nn	_
59	Living	living	NNP	p2=VBG	56	pobj	_
60	with	with	IN	_	55	prep	55:A2=MNR
61	Heart	heart	NNP	p2=NN	62	nn	_
62	Failure	failure	NN	p2=NNP	63	nn	_
63	Questionnaire	questionnaire	NNP	p2=NN	60	pobj	_
64	(	(	-LRB-	_	65	punct	_
65	MLWHQ	mlwhq	NNP	_	63	appos	_
66	)	)	-RRB-	_	65	punct	_
67	and	and	CC	_	63	cc	_
68	six	#crd#	CD	_	69	num	_
69	minute	minute	NN	p2=JJ	71	nn	_
70	walk	walk	NN	p2=VB	71	nn	_
71	distance	distance	NN	_	63	conj	_
72	(	(	-LRB-	_	71	punct	_
73	6MWD	6mwd	NNP	p2=CD	71	appos	_
74	)	)	-RRB-	_	71	punct	_
75	,	,	,	_	71	punct	_
76	respectively	respectively	RB	_	55	advmod	_
77	.	.	.	_	18	punct	_

1	Endpoints	endpoint	NNS	p2=NNPS	6	nsubj	6:A2=GOL
2	of	of	IN	_	1	prep	_
3	STOP	stop	NNP	p2=NN	5	hmod	_
4	-	-	HYPH	p2=:	5	hyph	_
5	HF	hf	NNP	_	2	pobj	_
6	include	include	VBP	p2=NN|pb=include.01	0	root	_
7	objective	objective	JJ	p2=NN	9	amod	_
8	echocardiographic	echocardiographic	JJ	_	9	amod	_
9	parameters	parameter	NNS	_	6	dobj	6:A1=PPT
10	of	of	IN	_	9	prep	_
11	left	leave	VBN	p2=JJ|pb=leave.06	13	amod	_
12	ventricular	ventricular	JJ	p2=NN	13	amod	_
13	remodeling	remodeling	NN	p2=VBG	10	pobj	11:A1=PPT
14	and	and	CC	_	13	cc	_
15	biomarkers	biomarker	NNS	_	13	conj	_
16	as	as	RB	_	18	advmod	_
17	well	well	RB	_	18	advmod	_
18	as	as	IN	_	9	cc	_
19	subjective	subjective	JJ	_	21	amod	_
20	clinical	clinical	JJ	_	21	amod	_
21	measures	measure	NNS	_	9	conj	_
22	of	of	IN	_	21	prep	_
23	clinical	clinical	JJ	_	24	amod	_
24	status	status	NN	_	22	pobj	_
25	in	in	IN	_	24	prep	_
26	heart	heart	NN	_	27	nn	_
27	failure	failure	NN	_	28	nn	_
28	patients	patient	NNS	_	25	pobj	_
29	.	.	.	_	6	punct	_

1	About	about	RB	p2=IN	3	advmod	_
2	Juventas	juventas	NNP	_	3	nn	_
3	Therapeutics	therapeutics	NNP	p2=NNPS	0	root	_
4	,	,	,	_	3	punct	_
5	Inc	inc	NNP	_	3	appos	_
6	.	.	.	_	3	punct	_

1	Juventas	juventas	NNP	p2=NNS	2	nn	_
2	Therapeutics	therapeutics	NNP	p2=NNPS	4	nn	_
3	,	,	,	_	4	punct	_
4	Inc	inc	NNP	_	0	root	_
5	.	.	.	_	4	punct	_

1	,	,	,	_	2	punct	_
2	headquartered	headquarter	VBN	pb=headquarter.01	0	root	_
3	in	in	IN	_	2	prep	2:AM-LOC
4	Cleveland	cleveland	NNP	_	3	pobj	_
5	,	,	,	_	4	punct	_
6	Ohio	ohio	NNP	_	4	appos	_
7	,	,	,	_	17	punct	_
8	is	be	VBZ	_	17	aux	_
9	a	a	DT	_	16	det	_
10	privately	privately	RB	_	11	advmod	11:AM-MNR
11	held	hold	VBN	pb=hold.02	16	amod	_
12	clinical	clinical	JJ	_	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	stage	stage	NN	_	16	nn	_
15	biotechnology	biotechnology	NN	_	16	nn	_
16	company	company	NN	_	17	attr	17:A0=PAG;11:A1=PPT
17	developing	develop	VBG	pb=develop.02	0	root	_
18	a	a	DT	_	19	det	_
19	pipeline	pipeline	NN	_	17	dobj	17:A1=PRD
20	of	of	IN	_	19	prep	_
21	regenerative	regenerative	JJ	p2=NN	22	amod	_
22	therapies	therapy	NNS	_	20	pobj	_
23	to	to	TO	_	24	aux	_
24	treat	treat	VB	pb=treat.03	22	infmod	_
25	life	life	NN	_	27	hmod	_
26	-	-	HYPH	_	27	hyph	_
27	threatening	threaten	VBG	_	28	amod	_
28	diseases	disease	NNS	_	24	dobj	24:A1=PPT
29	.	.	.	_	17	punct	_

1	Founded	found	VBN	pb=found.01	14	advcl	14:AM-TMP
2	in	in	IN	_	1	prep	1:AM-TMP
3	2007	0	CD	_	2	pobj	_
4	with	with	IN	_	1	prep	1:AM-MNR
5	an	an	DT	_	7	det	_
6	exclusive	exclusive	JJ	_	7	amod	_
7	license	license	NN	_	4	pobj	_
8	from	from	IN	_	7	prep	_
9	Cleveland	cleveland	NNP	_	10	nn	_
10	Clinic	clinic	NNP	_	8	pobj	_
11	,	,	,	_	14	punct	_
12	Juventas	juventas	NNP	_	14	nsubj	14:A0=PAG
13	has	have	VBZ	_	14	aux	_
14	transitioned	transition	VBN	pb=transition.01	0	root	_
15	its	its	PRP$	_	17	poss	_
16	therapeutic	therapeutic	JJ	_	17	amod	_
17	platform	platform	NN	_	14	dobj	14:A1=PPT
18	from	from	IN	_	14	prep	14:A3=DIR
19	concept	concept	NN	_	18	pobj	_
20	to	to	IN	_	14	prep	14:A2=GOL
21	through	through	IN	_	20	prep	_
22	mid-stage	mid-stage	JJ	p2=NN	24	amod	_
23	clinical	clinical	JJ	_	24	amod	_
24	trials	trial	NNS	_	21	pobj	_
25	for	for	IN	_	24	prep	_
26	treatment	treatment	NN	_	25	pobj	_
27	of	of	IN	_	26	prep	_
28	heart	heart	NN	_	29	nn	_
29	failure	failure	NN	_	27	pobj	_
30	and	and	CC	_	26	cc	_
31	critical	critical	JJ	_	33	amod	_
32	limb	limb	NN	_	33	nn	_
33	ischemia	ischemia	NN	_	26	conj	_
34	.	.	.	_	14	punct	_

1	Investors	investor	NNS	_	2	nsubj	2:A2=GOL
2	include	include	VBP	pb=include.01	0	root	_
3	Triathlon	triathlon	NNP	_	6	nn	_
4	Medical	medical	NNP	_	6	nn	_
5	Venture	venture	NNP	_	6	nn	_
6	Partners	partner	NNPS	_	2	dobj	2:A1=PPT
7	,	,	,	_	6	punct	_
8	New	new	NNP	p2=NNPS	10	nn	_
9	Science	science	NNP	_	10	nn	_
10	Ventures	ventures	NNP	p2=NNPS	6	conj	_
11	,	,	,	_	10	punct	_
12	Fletcher	fletcher	NNP	_	14	nn	_
13	Spaght	spaght	NNP	_	14	nn	_
14	Ventures	ventures	NNP	p2=NNPS	10	conj	_
15	,	,	,	_	14	punct	_
16	Takeda	takeda	NNP	_	17	nn	_
17	Ventures	ventures	NNP	p2=NNPS	14	conj	_
18	,	,	,	_	17	punct	_
19	Venture	venture	NNP	p2=JJ	20	nn	_
20	Investors	investor	NNPS	p2=NNS	17	conj	_
21	,	,	,	_	20	punct	_
22	Early	early	RB	p2=NNP	24	advmod	_
23	Stage	stage	NNP	_	24	nn	_
24	Partners	partner	NNPS	_	20	conj	_
25	,	,	,	_	24	punct	_
26	Reservoir	reservoir	NNP	_	28	nn	_
27	Venture	venture	NNP	_	28	nn	_
28	Partners	partner	NNPS	p2=NNP	24	conj	_
29	,	,	,	_	28	punct	_
30	and	and	CC	_	28	cc	_
31	Cleveland	cleveland	NNP	_	32	nn	_
32	Clinic	clinic	NNP	_	28	conj	_
33	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	Company	company	NNP	p2=NN	5	nsubj	5:A0=PAG
3	has	have	VBZ	_	5	aux	_
4	also	also	RB	_	5	advmod	5:AM-DIS
5	received	receive	VBN	pb=receive.01	0	root	_
6	financial	financial	JJ	_	7	amod	_
7	support	support	NN	_	5	dobj	5:A1=PPT
8	through	through	IN	_	5	prep	5:AM-MNR
9	the	the	DT	_	26	det	_
10	Ohio	ohio	NNP	_	18	nn	_
11	Third	third	NNP	_	12	nn	_
12	Frontier	frontier	NNP	_	14	hmod	14:A0=PAG
13	-	-	HYPH	p2=.	14	hyph	_
14	funded	fund	VBN	pb=fund.01	16	amod	_
15	Global	global	NNP	p2=JJ	16	nn	_
16	Cardiovascular	cardiovascular	NNP	_	18	nn	_
17	Innovation	innovation	NNP	_	18	nn	_
18	Center	center	NNP	_	8	pobj	_
19	and	and	CC	_	18	cc	_
20	Center	center	NNP	_	18	conj	_
21	for	for	IN	_	20	prep	_
22	Stem	stem	NNP	_	23	nn	_
23	Cell	cell	NNP	_	21	pobj	_
24	&	&	CC	_	23	cc	_
25	Regenerative	regenerative	NNP	_	26	nn	_
26	Medicine	medicine	NNP	_	23	conj	_
27	.	.	.	_	5	punct	_

1	For	for	IN	_	6	prep	6:AM-DIS
2	more	more	JJR	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	,	,	,	_	6	punct	_
5	please	please	UH	p2=VB	6	intj	6:AM-DIS
6	visit	visit	VB	pb=visit.01	0	root	_
7	www.juventasinc.com	#url#	ADD	_	6	dobj	6:A1=COM
8	.	.	.	_	6	punct	_

1	Copyright	copyright	NN	_	0	root	_
2	©2014	©0	CD	p2=NN	1	punct	_
3	MarketWatch	marketwatch	NNP	p2=NN	1	npadvmod	_
4	,	,	,	_	3	punct	_
5	Inc	inc	NNP	_	3	appos	_
6	.	.	.	_	1	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Intraday	intraday	NNP	_	2	nn	_
2	Data	data	NNP	p2=NN	3	nsubj	3:A1
3	provided	provided	VBN	pb=provide.01	0	root	_
4	by	by	IN	_	3	agent	3:A0
5	SIX	six	NNP	_	7	nn	_
6	Financial	financial	NNP	_	7	nn	_
7	Information	information	NNP	p2=NN	4	pobj	_
8	and	and	CC	_	7	cc	_
9	subject	subject	JJ	p2=VB	7	conj	_
10	to	to	IN	_	9	prep	_
11	terms	term	NNS	_	10	pobj	_
12	of	of	IN	_	11	prep	_
13	use	use	NN	_	12	pobj	_
14	.	.	.	_	3	punct	_

1	Historical	historical	JJ	p2=NNP	9	amod	_
2	and	and	CC	_	1	cc	_
3	current	current	JJ	_	9	amod	_
4	end	end	NN	p2=JJ	8	hmod	_
5	-	-	HYPH	_	8	hyph	_
6	of	of	IN	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	day	day	NN	_	9	nn	_
9	data	datum	NNS	_	0	root	10:A1
10	provided	provided	VBN	pb=provide.01	9	partmod	_
11	by	by	IN	_	10	agent	10:A0
12	SIX	six	NNP	_	14	nn	_
13	Financial	financial	NNP	p2=JJ	14	nn	_
14	Information	information	NNP	p2=NN	11	pobj	_
15	.	.	.	_	9	punct	_

1	Intraday	intraday	JJ	p2=NNP	2	amod	_
2	data	datum	NNS	p2=NN	0	root	3:A1=PPT
3	delayed	delay	VBN	pb=delay.01	2	partmod	_
4	per	per	IN	_	3	prep	3:A2=TMP
5	exchange	exchange	NN	_	6	nn	_
6	requirements	requirement	NNS	_	4	pobj	_
7	.	.	.	_	2	punct	_

1	S&P	s&p	NNP	_	0	root	_
2	/	/	SYM	_	1	punct	_
3	Dow	dow	NNP	_	4	nn	_
4	Jones	jones	NNP	_	7	nn	_
5	Indices	indices	NNP	p2=NNPS	7	nn	_
6	(	(	-LRB-	_	7	punct	_
7	SM	sm	NNP	_	1	appos	_
8	)	)	-RRB-	_	1	punct	_
9	from	from	IN	_	1	prep	_
10	Dow	dow	NNP	_	11	nn	_
11	Jones	jones	NNP	_	15	nn	_
12	&	&	CC	_	11	cc	_
13	Company	company	NNP	_	11	conj	_
14	,	,	,	_	15	punct	_
15	Inc	inc	NNP	_	9	pobj	_
16	.	.	.	_	1	punct	_

1	All	all	DT	p2=PDT	2	det	_
2	quotes	quote	NNS	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	in	in	IN	_	3	prep	3:A2=PRD
5	local	local	JJ	_	7	amod	_
6	exchange	exchange	NN	_	7	nn	_
7	time	time	NN	_	4	pobj	_
8	.	.	.	_	3	punct	_

1	Real	real	JJ	_	2	amod	_
2	time	time	NN	_	5	nn	_
3	last	last	JJ	_	5	amod	_
4	sale	sale	NN	_	5	nn	_
5	data	datum	NNS	p2=NN	0	root	6:A1
6	provided	provided	VBN	pb=provide.01	5	partmod	_
7	by	by	IN	_	6	agent	6:A0
8	NASDAQ	nasdaq	NNP	_	7	pobj	_
9	.	.	.	_	2	punct	_

1	More	more	JJR	_	2	amod	_
2	information	information	NN	_	5	nsubj	5:A0=PAG
3	on	on	IN	_	2	prep	_
4	NASDAQ	nasdaq	NNP	_	3	pobj	_
5	traded	trade	VBD	p2=VBN|pb=trade.01	0	root	_
6	symbols	symbol	NNS	_	5	dobj	5:A1=PPT
7	and	and	CC	_	6	cc	_
8	their	their	PRP$	_	11	poss	_
9	current	current	JJ	_	11	amod	_
10	financial	financial	JJ	_	11	amod	_
11	status	status	NN	_	6	conj	_
12	.	.	.	_	5	punct	_

1	Intraday	intraday	NNP	p2=JJ	2	nn	_
2	data	datum	NNS	p2=NN	3	nsubj	3:A0=PAG
3	delayed	delay	VBD	pb=delay.01	0	root	_
4	15	0	CD	_	5	num	_
5	minutes	minute	NNS	_	3	dobj	3:A1=PPT
6	for	for	IN	_	5	prep	_
7	Nasdaq	nasdaq	NNP	_	6	pobj	_
8	,	,	,	_	3	punct	_
9	and	and	CC	_	3	cc	_
10	20	0	CD	_	11	num	_
11	minutes	minute	NNS	_	3	conj	_
12	for	for	IN	_	11	prep	_
13	other	other	JJ	_	14	amod	_
14	exchanges	exchange	NNS	_	12	pobj	_
15	.	.	.	_	3	punct	_

1	S&P	s&p	NNP	_	0	root	_
2	/	/	SYM	_	1	punct	_
3	Dow	dow	NNP	_	4	nn	_
4	Jones	jones	NNP	_	7	nn	_
5	Indices	indices	NNP	p2=NNPS	7	nn	_
6	(	(	-LRB-	_	7	punct	_
7	SM	sm	NNP	_	1	appos	_
8	)	)	-RRB-	_	1	punct	_
9	from	from	IN	_	1	prep	_
10	Dow	dow	NNP	_	11	nn	_
11	Jones	jones	NNP	_	15	nn	_
12	&	&	CC	_	11	cc	_
13	Company	company	NNP	_	11	conj	_
14	,	,	,	_	15	punct	_
15	Inc	inc	NNP	_	9	pobj	_
16	.	.	.	_	1	punct	_

1	SEHK	sehk	NN	p2=NNP	3	nn	_
2	intraday	intraday	NN	_	3	nn	_
3	data	datum	NNS	p2=NN	5	nsubjpass	5:A1;11:A1=PPT
4	is	be	VBZ	_	5	auxpass	_
5	provided	provided	VBN	pb=provide.01	0	root	_
6	by	by	IN	_	5	agent	5:A0
7	SIX	six	NNP	_	9	nn	_
8	Financial	financial	NNP	_	9	nn	_
9	Information	information	NNP	p2=NN	6	pobj	_
10	and	and	CC	_	5	cc	_
11	is	be	VBZ	pb=be.01	5	conj	_
12	at	at	IN	_	13	advmod	_
13	least	least	JJS	_	14	advmod	_
14	60	0	CD	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	minutes	minute	NNS	_	17	npadvmod	17:A1=PPT
17	delayed	delay	VBN	p2=VBD|pb=delay.01	11	acomp	11:A2=PRD
18	.	.	.	_	5	punct	_

1	All	all	DT	p2=PDT	2	det	_
2	quotes	quote	NNS	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	in	in	IN	_	3	prep	3:A2=PRD
5	local	local	JJ	_	7	amod	_
6	exchange	exchange	NN	_	7	nn	_
7	time	time	NN	_	4	pobj	_
8	.	.	.	_	3	punct	_

